Dog,

I am disappointed with the lack of news/SEC filings; appears Dr G and his board remain clueless regards their fiduciary responsibilities in managing a publicly traded company.

I have suspended buying shares of the Company and offering supportive public statements until Cardiogenics informs its shareholders how the company is financed and presents the results of a head-to-head comparison study of the POC analyzer.

As to the "quietness" of this board - I prefer this to the nonsensical posting that RB offers its readers. Surely you no longer waste your time posting with that crew of individuals.

Ante